Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
F 234.36 5.50% 12.21
PEN closed up 5.5 percent on Monday, March 18, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 5.50%
Down 3 Days in a Row Weakness 5.50%
Down 4 Days in a Row Weakness 5.50%
Down 5 Days in a Row Weakness 5.50%
Oversold Stochastic Weakness 5.50%
Down 3 Days in a Row Weakness 2.10%
Down 4 Days in a Row Weakness 2.10%

   Recent Intraday Alerts

Alert Time
Up 5% about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Up 1 ATR about 15 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Up 3% about 15 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Penumbra, Inc. Description

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Health Care Catheter Interventional Radiology Vascular Access Products Neuron Stent Surgical Tools Thrombectomy

Is PEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 348.67
52 Week Low 180.93
Average Volume 331,036
200-Day Moving Average 258.02
50-Day Moving Average 251.09
20-Day Moving Average 242.36
10-Day Moving Average 240.37
Average True Range 9.66
RSI (14) 43.50
ADX 20.16
+DI 18.29
-DI 30.82
Chandelier Exit (Long, 3 ATRs) 248.36
Chandelier Exit (Short, 3 ATRs) 249.80
Upper Bollinger Bands 266.70
Lower Bollinger Band 218.01
Percent B (%b) 0.34
BandWidth 20.09
MACD Line -5.92
MACD Signal Line -4.22
MACD Histogram -1.6955
Fundamentals Value
Market Cap 9.05 Billion
Num Shares 38.6 Million
EPS 1.04
Price-to-Earnings (P/E) Ratio 225.35
Price-to-Sales 10.42
Price-to-Book 9.54
PEG Ratio -62.27
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 253.80
Resistance 3 (R3) 252.04 243.80 250.56
Resistance 2 (R2) 243.80 238.85 244.68 249.48
Resistance 1 (R1) 239.08 235.79 241.44 240.84 248.40
Pivot Point 230.84 230.84 232.02 231.72 230.84
Support 1 (S1) 226.12 225.89 228.48 227.88 220.32
Support 2 (S2) 217.88 222.83 218.76 219.24
Support 3 (S3) 213.16 217.88 218.16
Support 4 (S4) 214.92